2024 annual financial data

Liminatus Pharma 2024 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -2,906,319 USD and net income was -2,904,299 USD.
Operating cash flow was -3,106,462 USD.

Get free Liminatus Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-2,906,319 USD
Net income
-2,904,299 USD
Operating cash flow
-3,106,462 USD